Earnings History Data for Acumen Pharmaceuticals, Inc. (ABOS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It involved in developing a novel disease for Alzheimer. The company's product pipeline consist ACU193. Acumen Pharmaceuticals Inc. is based in CHARLOTTESVILLE, Va.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-03-2024 | PM | ABOS | Acumen Pharmaceuticals, Inc. | 250.75 | -0.29 | -0.29 | -0.32 | Acumen Pharmaceuticals GAAP EPS of -$1.08 [3/26/2024 7:03 AM] |
3.74 | -0.51 (-12.00%) |
4.57 | 0.32 (7.53%) |
1.81 - 11.31 | 1,308,875 | 280,000 | 411 | ||
| 13-11-2023 | PM | ABOS | Acumen Pharmaceuticals, Inc. | 107.64 | -0.24 | -0.31 | -0.26 | Acumen Pharmaceuticals GAAP EPS of -$0.24 beats by $0.03 [11/13/2023 7:10 AM] |
2.04 | 0.14 (7.11%) |
1.99 | 0.09 (4.74%) |
1.81 - 11.31 | 910,033 | 850,000 | 26,111 | ||
| 08-08-2023 | PM | ABOS | Acumen Pharmaceuticals, Inc. | 299.48 | -0.28 | -0.36 | -0.25 | Acumen Pharmaceuticals GAAP EPS of -$0.28 beats by $0.07 [8/8/2023 7:43 AM] |
6.98 | -0.02 (-0.29%) |
7.00 | 0.0 (0.00%) |
3.52 - 11.31 | 869,891 | 740,000 | 12,520 | ||
| 09-05-2023 | PM | Before the open (May 9) |
ABOS | Acumen Pharmaceuticals, Inc. | 217.02 | -0.28 | -0.33 | -0.23 | Acumen Pharmaceuticals GAAP EPS of -$0.28 beats by $0.06 [5/9/2023 10:06 AM] |
5.72 | 0.88 (18.04%) |
4.89 | 0.04 (0.82%) |
3.02 - 10.97 | 502,329 | 340,000 | 1,239 | |
| 27-03-2023 | PM | Before the open (Mar 27) |
ABOS | Acumen Pharmaceuticals, Inc. | 217.31 | -0.32 | -0.29 | 0.00 | Acumen Pharmaceuticals GAAP EPS of -$1.06 misses by $0.08 [3/27/2023 7:04 AM] |
4.01 | 0.09 (2.30%) |
0.0 | 0.0 (0.00%) |
3.02 - 10.97 | 92,506 | 130,000 | 0 | |
| 14-11-2022 | AH | 4:05 PM ET (Nov 14) |
ABOS | Acumen Pharmaceuticals, Inc. | 262.46 | -0.26 | -0.27 | -0.10 | Acumen Pharmaceuticals GAAP EPS of -$0.26 [11/14/2022 4:11 PM] |
6.42 | 0.28 (4.56%) |
6.00 | -0.80 (-11.76%) |
3.02 - 13.21 | 265,882 | 140,000 | 15,578 | |
| 15-08-2022 | AH | 4:05 PM ET (Aug 15) |
ABOS | Acumen Pharmaceuticals, Inc. | 254.35 | -0.25 | -0.24 | -7.91 | Acumen Pharmaceuticals GAAP EPS of -$0.25 in-line [8/15/2022 4:18 PM] |
5.69 | 0.28 (5.18%) |
5.41 | 0.0 (0.00%) |
3.02 - 19.46 | 44,681 | 40,000 | 251 | |
| 16-05-2022 | AH | 4:05 PM ET (May 16) |
ABOS | Acumen Pharmaceuticals, Inc. | 128.78 | -0.23 | 0.00 | 0.00 | Acumen Pharmaceuticals GAAP EPS of -$0.23 misses by $0.06 [5/16/2022 4:21 PM] |
3.62 | 0.39 (12.07%) |
3.23 | 0.0 (0.00%) |
3.02 - 26.98 | 201,007 | 220,000 | 2,553 | |
| 28-03-2022 | AH | 4:05 PM ET (Mar 28) |
ABOS | Acumen Pharmaceuticals, Inc. | 229.47 | N/A | -0.21 | 0.00 | Acumen Pharmaceuticals GAAP EPS of -$5.02 misses by $1.56 [3/28/2022 4:14 PM] |
4.38 | -0.28 (-6.01%) |
4.50 | -0.16 (-3.43%) |
4.30 - 26.98 | 295,611 | 410,000 | 1,463 | |